Literature DB >> 7709996

The surface membrane antigen phenotype of human blood basophils.

W Füreder1, H Agis, W R Sperr, K Lechner, P Valent.   

Abstract

Basophils are effector cells of allergic reactions and express a unique profile of cellular antigens (Ag). Using a combined toluidine-blue/immunofluorescence staining method, we were able to study the cell membrane Ag phenotype of normal human blood basophils with monoclonal antibodies (mAbs) against established and novel CD antigens. According to previous findings, basophils express CD9 (p24), CD11a (LFA-1 alpha-chain), CD11b (C3biR), CD11c (CR4), CD13 (aminopeptidase N), CDw17 (lactosylceramide), CD18 (beta-chain of beta 2), CD25 (IL-2R alpha-chain), CD26 (dipeptidylpeptidase), CD31 (PECAM), CD35 (CR1), CD38 (T10), CD43 (leukosialin), CD44 (Pgp-1), CD45 (pan-leukocyte Ag), and CD63 (basophil activation Ag). Various novel CD Ags were detected on basophils, including membrane cofactor protein (MCP) (CD46), the N-linked glycan CD47, decay-accelerating factor (DAF) (CD55), membrane attack complex inhibitory factor (MACIF) (CD59), LFA-3 (CD58), ICAM-2 (CD 102), ICAM-3 (CD50), C5a receptor (CD88), MIC-2/E2 (CD99), and the interleukin-1 (IL-1) R type II (CD121b). These data provide further evidence that basophils express a unique profile of surface membrane receptors for cytokines and immunomodulating compounds, as well as adhesion molecules and surface glycolipids.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7709996     DOI: 10.1111/j.1398-9995.1994.tb00788.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

1.  Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.

Authors:  M Jack Borrok; Nadia M Luheshi; Nurten Beyaz; Gareth C Davies; James W Legg; Herren Wu; William F Dall'Acqua; Ping Tsui
Journal:  MAbs       Date:  2015       Impact factor: 5.857

2.  Detection of allergen-induced basophil activation by expression of CD63 antigen using a tricolour flow cytometric method.

Authors:  G Monneret; M C Gutowski; J Bienvenu
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

3.  Differential response of human basophils and mast cells to recombinant chemokines.

Authors:  W Füreder; H Agis; H Semper; F Keil; U Maier; M R Müller; K Czerwenka; H Höfler; K Lechner; P Valent
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

4.  Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7.

Authors:  H Agis; M-T Krauth; I Mosberger; L Müllauer; I Simonitsch-Klupp; L B Schwartz; D Printz; A Böhm; G Fritsch; H-P Horny; P Valent
Journal:  J Clin Pathol       Date:  2006-02-03       Impact factor: 3.411

5.  The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives.

Authors:  Radhia Boumiza; Anne-Lise Debard; Guillaume Monneret
Journal:  Clin Mol Allergy       Date:  2005-06-30

6.  Overexpression of FcεRI on Bone Marrow Mast Cells, but Not MRGPRX2, in Clonal Mast Cell Disorders With Wasp Venom Anaphylaxis.

Authors:  Jessy Elst; Leander P De Puysseleyr; Didier G Ebo; Margaretha A Faber; Athina L Van Gasse; Marie-Line M van der Poorten; Ine I Decuyper; Chris H Bridts; Christel Mertens; Michel Van Houdt; Margo M Hagendorens; Luc S De Clerck; Anke Verlinden; Katrien Vermeulen; Marie-Berthe Maes; Zwi N Berneman; Peter Valent; Vito Sabato
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

7.  MHC class II expression in human basophils: induction and lack of functional significance.

Authors:  Astrid L Voskamp; Sara R Prickett; Fabienne Mackay; Jennifer M Rolland; Robyn E O'Hehir
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.